Published in Radiology on January 21, 2009
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol (2012) 2.00
Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 1.33
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst (2010) 1.29
Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev (2011) 1.19
Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol (2012) 1.01
Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care (2012) 0.99
A comprehensive methodology for determining the most informative mammographic features. J Digit Imaging (2013) 0.98
Breast cancer risk prediction model: a nomogram based on common mammographic screening findings. Eur Radiol (2013) 0.93
Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain. Eur Radiol (2011) 0.92
Using natural language processing to extract mammographic findings. J Biomed Inform (2015) 0.84
The association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohort. Cancer (2016) 0.80
Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer. PLoS One (2016) 0.79
Response of bilateral breasts to the endogenous hormonal fluctuation in a menstrual cycle evaluated using 3D MRI. Magn Reson Imaging (2012) 0.75
Ductal carcinoma arising from ectopic breast tissue following microcalcification observed on screening mammography: a case report and review of the literature. J Breast Cancer (2014) 0.75
Noninferiority and Equivalence Evaluation of Clinical Performance among Computed Radiography, Film, and Digitized Film for Telemammography Services. Int J Telemed Appl (2016) 0.75
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
Empirical evidence of design-related bias in studies of diagnostic tests. JAMA (1999) 12.96
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology (1991) 4.84
The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol (1998) 2.47
The positive predictive value of mammography. AJR Am J Roentgenol (1992) 2.08
Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology (1992) 1.79
Revisiting the mammographic follow-up of BI-RADS category 3 lesions. AJR Am J Roentgenol (2002) 1.45
Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology (2001) 1.35
Likelihood of malignant disease for various categories of mammographically detected, nonpalpable breast lesions. Mayo Clin Proc (1993) 1.32
Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol (2003) 1.12
Mammographic follow-up of low-suspicion lesions: compliance rate and diagnostic yield. Radiology (1991) 1.09
The predictive value of certain mammographic signs in screening for breast cancer. Cancer (1983) 1.08
Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology (1987) 1.00
The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesions. Clin Radiol (1996) 0.99
The impact of mammography on breast biopsy. Am Surg (1992) 0.95
Findings at mammographic screening on only one standard projection: outcomes analysis. Radiology (1998) 0.93
Occult malignant breast lesions in 114 patients: relationship to age and the presence of microcalcifications. Radiology (1988) 0.89
Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings. AJR Am J Roentgenol (2007) 0.86
The spectrum of breast asymmetries: imaging features, work-up, management. Radiol Clin North Am (2007) 0.86
Non-palpable lesions of the breast detected by mammography--review of 1182 consecutive histologically confirmed cases. Eur J Cancer (1994) 0.82
Positive predictive value of BI-RADS categorization in an Asian population. Asian J Surg (2004) 0.81
A prospective study of 8413 asymptomatic women undergoing mammography. Can Assoc Radiol J (1990) 0.79
Not all nonpalpable breast cancers are alike. Arch Surg (1991) 0.78
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Influence of computer-aided detection on performance of screening mammography. N Engl J Med (2007) 8.58
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med (2004) 6.42
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology (2003) 3.90
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell (2007) 3.44
Association of volume and volume-independent factors with accuracy in screening mammogram interpretation. J Natl Cancer Inst (2003) 3.41
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) (2008) 3.02
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
The ACR BI-RADS experience: learning from history. J Am Coll Radiol (2009) 2.68
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat (2005) 2.53
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov (2012) 2.51
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology (2002) 2.36
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology (2013) 2.27
Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer (2008) 2.23
Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med (2003) 2.20
Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.18
To seek perfection or not? That is the question. Radiology (2012) 2.15
Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology (2012) 2.07
Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA (2004) 2.07
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control (2014) 2.05
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome. Prenat Diagn (2007) 2.03
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Mammographic breast density and family history of breast cancer. J Natl Cancer Inst (2003) 1.95
Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst (2007) 1.95
Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer (2006) 1.92
Trends in colonoscopy for colorectal cancer screening. Med Care (2007) 1.89
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst (2012) 1.80
Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.78
Novel use of single X-ray absorptiometry for measuring breast density. Technol Cancer Res Treat (2005) 1.78
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology (2005) 1.75
Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst (2002) 1.70
Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care (2006) 1.70
Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst (2008) 1.61
Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. Med Phys (2009) 1.58
Analysis of 172 subtle findings on prior normal mammograms in women with breast cancer detected at follow-up screening. Radiology (2003) 1.55
Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease. Radiology (2002) 1.53
Physician workload in mammography. AJR Am J Roentgenol (2008) 1.53
Screening mammography in the American elderly. Am J Prev Med (2006) 1.52
Comparing the performance of mammography screening in the USA and the UK. J Med Screen (2005) 1.52
Short-interval follow-up mammography: are we doing the right thing? J Natl Cancer Inst (2003) 1.49
Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol (2010) 1.49
Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst (2013) 1.48
Disclosing harmful mammography errors to patients. Radiology (2009) 1.45
Airport full-body screening: what is the risk? Arch Intern Med (2011) 1.45
Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volume. Radiology (2011) 1.44
Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®). Catheter Cardiovasc Interv (2013) 1.43
Perceived risk of breast cancer among women at average and increased risk. J Womens Health (Larchmt) (2005) 1.41
The ACR/Society of Breast Imaging Resident and Fellowship Training Curriculum for Breast Imaging, updated. J Am Coll Radiol (2012) 1.40
Evidence-based target recall rates for screening mammography. Radiology (2007) 1.39
Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev (2012) 1.39
Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev (2006) 1.39
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas (2010) 1.38
Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States. Circulation (2010) 1.38
Measurement of breast density with dual X-ray absorptiometry: feasibility. Radiology (2002) 1.38
The mammogram that cried Wolfe. N Engl J Med (2007) 1.37
Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care (2014) 1.37
Differences in the quality of breast cancer care among vulnerable populations. Cancer (2005) 1.36
Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35